Loading stock data…
CAH
$197.00-0.06 (-0.03%)
Pre-Market$196.69-0.31 (-0.16%)· Last close May 5
Cardinal Health, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cardinal Health, Inc. in the Healthcare sector is trading at $197.00. The stock is currently 16% below its 52-week high of $233.60, remaining 4.3% above its 200-day moving average. Technical signals show neutral RSI of 34 and bearish MACD signal, explaining why CAH maintains its current momentum and trend strength. The Whystock Score of 95/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Oversold momentum (RSI 34) — potential for technical mean-reversion
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$197.00
Potential Downside
77.6%
Whystock Fair Value$44.19
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus15 analysts
Mean target$247.13+25.4%
Range$215.00 – $275.00
Fundamentals
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company prov...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$47.13B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
28.86
Beta
Defensive asset. Lower volatility than the S&P 500.
0.65
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.04%
ROE
Average efficiency. Growth may require heavy reinvestment.
-57.63%
Volume
Today's trading volume
996,633
Recent News
Do Options Traders Know Something About Cardinal Health Stock We Don't?
Investors need to pay close attention to CAH stock based on the movements in the options market lately.
Cardinal Health (CAH) Valuation Check After Strong Long Term Shareholder Returns
Why Cardinal Health Stock Is Drawing Fresh Attention Cardinal Health (CAH) is back on investors’ radar after a recent share move, with the stock closing at $197.06 as the company posts annual revenue of $250.7b and net income of $1.6b. See our latest analysis for Cardinal Health. The latest move in Cardinal Health’s share price comes after a strong run, with the stock posting a 31.12% 1 year total shareholder return and a very large 279.11% 5 year total shareholder return. This is occurring...
Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down
INSP beats Q1 estimates but slashes 2026 outlook as reimbursement disruptions and WISeR program weigh on growth and procedure volumes.
RVTY Q1 Earnings Beat Estimates on Organic Growth & Strong Execution
Revvity beat Q1 EPS and revenue estimates as 3% organic growth and portfolio execution offset margin pressure and China ImmunoDx divest plans.
Is Cardinal (CAH) a Solid Growth Stock? 3 Reasons to Think "Yes"
Cardinal (CAH) is well positioned to outperform the market, as it exhibits above-average growth in financials.